Evidence map›Paper›PMID 40876545›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2025

Computation-aided design of rod-shaped nanoparticles for tumoral targeting.

Jinhyung Lee, Wuxia Zhang, Danh Nguyen, Libo Zhou, Justin Amengual, Jin Zhai, Trystin Cote, Maxwell Landolina, Elham Ahmadi, Ian Sands and 6 more

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Jinhyung LeeDepartment of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, United States of America.
Wuxia ZhangDepartment of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, United States of America.
Danh NguyenDepartment of Mechanical Engineering, University of Wisconsin-Madison, Madison, WI 53706, United States of America.
Libo ZhouDepartment of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, United States of America.
Justin AmengualPolymer Program, Institute of Materials Science, University of Connecticut, Storrs, CT 06269, United States of America.
Jin ZhaiDepartment of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, United States of America.
Trystin CoteDepartment of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, United States of America.
Maxwell LandolinaDepartment of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, United States of America.
Elham AhmadiDepartment of Immunology, University of Connecticut Health Center, Farmington, CT 06030, United States of America.
Ian SandsDepartment of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, United States of America.
Neha MishraDepartment of Pathobiology and Veterinary Science, University of Connecticut Health Center, Farmington, CT 06030, United States of America.
Hongchuan YuThe Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI 02903, United States of America.
Mu-Ping NiehPolymer Program, Institute of Materials Science, University of Connecticut, Storrs, CT 06269, United States of America; Department of Chemical and Biomolecular Engineering, University of Connecticut, Storrs, CT 06269, United States of America.
Kepeng WangDepartment of Immunology, University of Connecticut Health Center, Farmington, CT 06030, United States of America. Electronic address: kewang@uchc.edu.
Ying LiDepartment of Mechanical Engineering, University of Wisconsin-Madison, Madison, WI 53706, United States of America. Electronic address: yli2562@wisc.edu.
Yupeng ChenDepartment of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, United States of America. Electronic address: yupeng.chen@uconn.edu.

Funding

X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Sean McSweeney · 2019 to 2026
$38.6M
Pilot Projects ProgramP30GM122732 · NIGMS · RHODE ISLAND HOSPITAL · PI CRISCO, JOSEPH J · 2017 to 2021
$6.6M
Supplement: Developing Nanomaterial Platform for Intra-Cartilage Delivery of RNA Therapeutics against Joint DiseasesR01AR072027 · NIAMS · UNIVERSITY OF CONNECTICUT STORRS · PI CHEN, YUPENG · 2017 to 2022
$2.3M
Control of regulatory T cells by IL-17 in colorectal cancerR01CA262430 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI WANG, KEPENG · 2021 to 2025
$1.8M
Computation-aided Molecular Design of DNA-Inspired Janus Base Biomaterials for Intracellular DeliveryR01GM155969 · NIGMS · UNIVERSITY OF CONNECTICUT STORRS · PI Yupeng Chen · 2024 to 2026
$1.2M
Layer-by-Layer Nano Matrix for Growth Plate RegenerationR21AR079153 · NIAMS · UNIVERSITY OF CONNECTICUT STORRS · PI CHEN, YUPENG · 2022 to 2023
$393k
NCI NIH HHS R01 CA262430NIAMS NIH HHS R01 AR072027NIAMS NIH HHS R21 AR079153NIGMS NIH HHS P30 GM122732NIGMS NIH HHS P30 GM133893NIGMS NIH HHS R01 GM155969
6 · The paper itself

Abstract

Various nanomaterials have been developed for drug delivery, but the vast majority are spherical nanoparticles (50-500 nm in diameter). This limits their ability to target and infiltrate hard-to-penetrate tissues, such as certain solid tumors with a dense extracellular matrix (ECM). To investigate how the key physical parameter of shape influences tumor targeting, we developed Janus base nanoparticles (JBNps), a family of rod-shaped delivery vehicles that self-assemble into nanotube bundles with encapsulated drug cargos. In a head-to-head comparison with spherical nanoparticles, the rod-shaped JBNps enabled significantly better tumor infiltration and targeting (by 300 %) of an ECM-rich adenocarcinoma model. To efficiently optimize formulations, we employed a computation-aided methodology to refine drug loading and design parameters, which achieved maximal drug loading efficiency (by 97 %). This work provides a broadly applicable strategy for designing nanoparticles and highlights the potential of exploiting the physical shape of nanoparticles to achieve enhanced penetration and targeting of solid tumors.

Indexed as

AdenocarcinomaAntineoplastic AgentsDrug CarriersDrug Delivery SystemsNanoparticlesNeoplasmsAnimalsCell Line, TumorComputer-Aided DesignHumansAntineoplastic AgentsDrug CarriersComputation-aided designDrug deliveryNanomaterialsRod-shaped nanoparticles

Identifiers

PMID40876545
PMCPMC13382647

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.